cigna glp-1 news dropping all coverage effective 7/1 : r/Zepbound Cigna reaches new deal on
Description
Mast cell activation syndrome and genetics
After pulling its ALS drug Relyvrio from the market, Amylyx Pharmaceuticals is looking to target the GLP-1 space with the purchase of Eiger BioPharmaceuticals avexitide, which has been studied for the treatment of hyperinsulinemic hypoglycemia.
The GLP-1 market is expected to hit $200 billion by 2031, according to a new study.
Add 7 ounces of cold water to a shaker cup
Discover how GLP-1 medications are reshaping the food and beverage industry, driving demand for smaller-portion, nutrient-dense products
